Electrolyte Disorders: Pathophysiology, Diagnosis, and Management

Electrolytes are essential ions that maintain cellular function, fluid balance, and acid-base homeostasis. The primary electrolytes include sodium (Na+), potassium (K+), calcium (Ca²+), magnesium (Mg²+), chloride (Cl-), and phosphate (PO₄³-). The kidneys play a central role in electrolyte regulation through filtration, reabsorption, and secretion mechanisms.

Sodium Regulation: Sodium is the primary extracellular cation, determining plasma osmolality and extracellular fluid volume. Normal serum sodium ranges from 135-145 mEq/L (135-145 mmol/L). The renin-angiotensin-aldosterone system (RAAS) and antidiuretic hormone (ADH) primarily regulate sodium homeostasis. Sodium reabsorption occurs throughout the nephron, with 65% in the proximal tubule, 25% in the thick ascending limb of Henle, and 5-10% in the distal convoluted tubule and collecting duct.

Potassium Regulation: Potassium is the primary intracellular cation, essential for membrane potential and cellular function. Normal serum potassium ranges from 3.5-5.0 mEq/L (3.5-5.0 mmol/L). The kidneys excrete 90% of daily potassium intake, primarily through aldosterone-mediated secretion in the collecting duct. The Na-K-ATPase pump maintains the intracellular-extracellular gradient.

Calcium Regulation: Calcium exists in three forms: ionized (45%), protein-bound (45%), and complexed (10%). Normal total serum calcium is 8.5-10.5 mg/dL (2.1-2.6 mmol/L), with ionized calcium at 4.5-5.5 mg/dL (1.1-1.4 mmol/L). Parathyroid hormone (PTH), calcitriol (1,25-dihydroxyvitamin D₃), and calcitonin regulate calcium homeostasis through effects on bone, kidneys, and intestines.

Clinical Significance: Electrolyte disorders can result from altered intake, distribution, or excretion. Understanding the underlying pathophysiology is crucial for proper diagnosis and management, as inappropriate correction can lead to severe complications including cerebral edema, cardiac arrhythmias, and osmotic demyelination syndrome.

Hyponatremia, defined as serum sodium <135 mEq/L, is the most common electrolyte disorder in hospitalized patients. Understanding the pathophysiology requires assessment of volume status and plasma osmolality.

Pathophysiological Classification:

1. Hypotonic Hyponatremia (most common)

   • Hypovolemic: Loss of sodium > water (diarrhea, diuretics, cerebral salt wasting)
   • Euvolemic: Water retention without sodium loss (SIADH, hypothyroidism, cortisol deficiency)
   • Hypervolemic: Water retention > sodium retention (heart failure, cirrhosis, nephrotic syndrome)

2. Isotonic Hyponatremia (pseudohyponatremia)

   • Severe hyperlipidemia or hyperproteinemia

3. Hypertonic Hyponatremia

   • Hyperglycemia, mannitol administration

SIADH Criteria:

• Hyponatremia with inappropriately concentrated urine (>100 mOsm/kg)
• Euvolemic state
• Normal thyroid and adrenal function
• Urine sodium >40 mEq/L on normal salt intake

Diagnostic Algorithm:

Hyponatremia (Na+ <135 mEq/L) | ├─ Plasma osmolality │ ├─ Low (<280 mOsm/kg) → Hypotonic │ ├─ Normal (280-295) → Isotonic (pseudohyponatremia) │ └─ High (>295) → Hypertonic (glucose, mannitol) │ └─ Volume status assessment ├─ Hypovolemic → Check urine Na+ │ ├─ <30 mEq/L → Extrarenal losses │ └─ >30 mEq/L → Renal losses ├─ Euvolemic → Consider SIADH, hypothyroidism └─ Hypervolemic → CHF, cirrhosis, nephrotic syndrome

Clinical Manifestations: Symptoms depend on severity and rate of development. Acute hyponatremia (<48 hours) causes cerebral edema: headache, nausea, confusion, seizures, coma. Chronic hyponatremia may be asymptomatic due to cellular adaptation through organic osmolyte loss.

Hypernatremia (serum sodium >145 mEq/L) represents a state of relative water deficit compared to sodium. It always indicates hyperosmolality and stimulates thirst and ADH release in normal individuals.

Pathophysiological Mechanisms:

1. Water Loss

   • Renal: Central or nephrogenic diabetes insipidus, osmotic diuresis
   • Extrarenal: Respiratory, cutaneous, gastrointestinal losses

2. Sodium Gain

   • Hypertonic saline administration
   • Mineralocorticoid excess
   • Salt ingestion (rare)

Diabetes Insipidus Classification:

• Central DI: ADH deficiency (trauma, tumors, surgery, genetic)
• Nephrogenic DI: Renal resistance to ADH (lithium, hypercalcemia, hypokalemia, genetic)

Diagnostic Workup:

Hypernatremia (Na+ >145 mEq/L) | ├─ Volume status │ ├─ Hypovolemic → Water loss > Na+ loss │ │ ├─ Urine osmolality >600 mOsm/kg → Extrarenal losses │ │ └─ Urine osmolality <600 mOsm/kg → Renal losses │ ├─ Euvolemic → Pure water loss │ │ └─ Consider diabetes insipidus │ └─ Hypervolemic → Na+ gain │ └─ Hypertonic fluid administration │ └─ Water deprivation test (if DI suspected) ├─ Normal response → Primary polydipsia ├─ No concentration + responds to DDAVP → Central DI └─ No concentration + no DDAVP response → Nephrogenic DI

Clinical Manifestations: Neurological symptoms predominate due to cellular dehydration: altered mental status, weakness, neuromuscular irritability, seizures, coma. Symptoms are more severe with rapid onset. Chronic hypernatremia allows cellular adaptation through organic osmolyte accumulation.

Risk Factors: Infants, elderly, and patients with altered mental status are at highest risk due to impaired thirst mechanism or inability to access water.

Hypokalemia (serum K+ <3.5 mEq/L) results from inadequate intake, increased losses, or transcellular shifts. Total body potassium depletion may be present despite normal serum levels.

Pathophysiological Mechanisms:

1. Increased Losses

   • Renal: Diuretics, hyperaldosteronism, RTA, hypomagnesemia
   • Gastrointestinal: Diarrhea, laxative abuse, fistulas

2. Transcellular Shifts

   • β₂-adrenergic stimulation (albuterol, stress)
   • Insulin therapy
   • Alkalemia
   • Hypokalemic periodic paralysis

3. Inadequate Intake (rare in normal kidney function)

Diagnostic Approach:

Hypokalemia (K+ <3.5 mEq/L) | ├─ Urine K+ excretion │ ├─ <15 mEq/day or TTKG <3 → Extrarenal losses │ │ └─ GI losses, inadequate intake, transcellular shift │ └─ >15 mEq/day or TTKG >4 → Renal losses │ | │ ├─ Normal BP → RTA, diuretics, Gitelman syndrome │ └─ High BP → Check aldosterone/renin │ ├─ High renin → Renovascular disease │ └─ Low renin → Primary aldosteronism │ └─ Associated findings ├─ Hypomagnesemia → Renal Mg wasting ├─ Metabolic alkalosis → Mineralocorticoid excess └─ Metabolic acidosis → RTA, diarrhea

Clinical Manifestations:

• Neuromuscular: Weakness, fatigue, cramps, paralysis, rhabdomyolysis
• Cardiac: Arrhythmias, prolonged QT, U waves, enhanced digitalis toxicity
• Renal: Polyuria, polydipsia (nephrogenic DI), chronic tubulointerstitial nephritis
• Gastrointestinal: Paralytic ileus, constipation

ECG Changes:

• ST depression
• T wave flattening/inversion
• U wave prominence
• QT prolongation
• Increased risk of torsades de pointes

Potassium-Magnesium Relationship: Hypomagnesemia impairs renal potassium conservation and must be corrected simultaneously. Approximately 50% of hypokalemic patients have concurrent hypomagnesemia.

Hyperkalemia (serum K+ >5.0 mEq/L) is a potentially life-threatening condition requiring immediate recognition and treatment. Pseudohyperkalemia should be excluded before initiating therapy.

Pathophysiological Mechanisms:

1. Increased Intake (rare with normal kidney function)

   • Dietary excess, salt substitutes, medications

2. Transcellular Shifts

   • Acidemia (non-organic acids)
   • Insulin deficiency
   • β-blocker therapy
   • Hyperkalemic periodic paralysis
   • Tissue necrosis, tumor lysis syndrome

3. Decreased Excretion

   • Kidney disease: Acute/chronic kidney injury
   • Medications: ACE inhibitors, ARBs, spironolactone, NSAIDs
   • Hyporeninemic hypoaldosteronism: Diabetes, aging

Pseudohyperkalemia Causes:

• Hemolysis during phlebotomy
• Thrombocytosis (>1,000,000/μL)
• Leukocytosis (>100,000/μL)
• Prolonged tourniquet application
• Fist clenching during blood draw

Diagnostic Evaluation:

Hyperkalemia (K+ >5.0 mEq/L) | ├─ Exclude pseudohyperkalemia │ ├─ Repeat sample, check plasma K+ │ └─ Review CBC for cytopenias │ ├─ Assess kidney function │ ├─ Normal GFR → Transcellular shift, medications │ └─ Reduced GFR → Impaired excretion │ └─ Evaluate aldosterone axis ├─ Low aldosterone → Adrenal insufficiency ├─ High aldosterone → Aldosterone resistance └─ Medications affecting RAAS

Clinical Manifestations:

• Cardiac: Most dangerous - peaked T waves, widened QRS, sine waves, asystole
• Neuromuscular: Weakness, paralysis, paresthesias
• Usually asymptomatic until severe (>6.5 mEq/L)

ECG Changes (Progressive):

1. Peaked T waves (earliest)
2. Prolonged PR interval
3. Loss of P waves
4. Widened QRS complex
5. Sine wave pattern
6. Ventricular fibrillation/asystole

Emergency Treatment Approach: Treatment urgency depends on ECG changes and potassium level, not just the absolute value.

Hyponatremia Correction:

Acute Severe Hyponatremia (<48 hours, symptoms):

Severe symptoms (seizures, coma) | ├─ 3% saline 1-2 mL/kg over 10-20 minutes ├─ Repeat until symptoms improve ├─ Target: 4-6 mEq/L increase in first 24h └─ Maximum: 8-12 mEq/L in 24h

Chronic Hyponatremia (>48 hours):

• Rate: 4-8 mEq/L per 24 hours (maximum 8-12 mEq/L)
• Avoid overcorrection: Risk of osmotic demyelination syndrome
• Formula: Na+ deficit = TBW × (desired Na+ - current Na+)
• TBW: 0.6 × weight (kg) for men, 0.5 × weight for women

Treatment by Cause:

• SIADH: Fluid restriction, demeclocycline, tolvaptan
• Hypovolemic: Normal saline replacement
• Hypervolemic: Diuretics, treat underlying condition

Hypernatremia Correction:

Hypernatremia correction | ├─ Calculate water deficit │ └─ Deficit = TBW × [(current Na+/140) - 1] │ ├─ Correction rate │ ├─ Acute (<24h): 1-2 mEq/L per hour │ └─ Chronic (>24h): 0.5 mEq/L per hour │ └─ Maximum 8-10 mEq/L per 24h │ └─ Fluid choice ├─ Hypovolemic → Normal saline initially ├─ Euvolemic → 5% dextrose or 0.45% saline └─ Hypervolemic → Furosemide + hypotonic fluids

Monitoring:

• Check sodium every 2-4 hours during active correction
• Neurological assessment for signs of cerebral edema
• Adjust rate based on clinical response

Complications of Rapid Correction:

• Hyponatremia: Osmotic demyelination syndrome (central pontine myelinolysis)
• Hypernatremia: Cerebral edema, seizures, intracerebral hemorrhage

Special Populations:

• Elderly: Lower correction rates due to increased risk
• Liver disease: Higher risk of osmotic demyelination
• Malnutrition: Increased susceptibility to complications

Hyperkalemia Management:

Emergency Treatment (K+ >6.5 mEq/L or ECG changes):

1. Membrane Stabilization (immediate) └─ Calcium gluconate 10% 1-2 amps IV over 2-5 min └─ Duration: 30-60 minutes, can repeat

2. Transcellular Shift (30-60 minutes) ├─ Regular insulin 10 units IV + D50 25g IV ├─ Albuterol 10-20mg nebulized └─ Sodium bicarbonate 50 mEq IV (if acidotic)

3. Potassium Removal (hours) ├─ Furosemide 40-80mg IV ├─ Patiromer or SPS resin PO └─ Hemodialysis (if severe/refractory)

Hypokalemia Replacement:

Oral Replacement (preferred):

• KCl 40-100 mEq daily in divided doses
• Each 13.4 mEq increases serum K+ by ~0.27 mEq/L

IV Replacement:

• Rate: Maximum 10-20 mEq/hour via central line
• Peripheral: Maximum 10 mEq/hour
• Concentration: ≤40 mEq/L peripherally, ≤60 mEq/L centrally
• Monitoring: Check K+ every 4-6 hours during replacement

Calcium Disorders:

Hypocalcemia Treatment:

Symptomatic hypocalcemia | ├─ Acute treatment │ ├─ Calcium gluconate 10% 1-2 amps IV │ └─ Calcium chloride 10% 0.5-1 amp IV (central line) │ ├─ Maintenance │ ├─ Calcium carbonate 1-2g PO BID-TID │ └─ Calcitriol 0.25-0.5 mcg BID │ └─ Correct hypomagnesemia concurrently └─ Magnesium sulfate 1-2g IV/IM

Hypercalcemia Treatment:

Severe hypercalcemia (>14 mg/dL) | ├─ Immediate measures │ ├─ Normal saline 200-300 mL/hour │ └─ Furosemide 20-40mg IV after rehydration │ ├─ Reduce bone resorption │ ├─ Pamidronate 60-90mg IV over 2-4 hours │ ├─ Zoledronic acid 4mg IV over 15 minutes │ └─ Calcitonin 4 units/kg SC/IM q12h │ └─ Treat underlying cause ├─ Malignancy → Chemotherapy ├─ Granulomatous → Corticosteroids └─ Primary hyperparathyroidism → Surgery

Monitoring Parameters:

• Potassium: ECG, serum levels every 4-6 hours during treatment
• Calcium: Ionized calcium preferred, check Mg²+ and PO₄³-
• Kidney function: Monitor during aggressive treatments
• Clinical symptoms: Neurological and cardiac assessments